Related references
Note: Only part of the references are listed.Predictive Value of Lipoprotein Indices for Residual Risk of Acute Myocardial Infarction and Sudden Death in Men With Low-Density Lipoprotein Cholesterol Levels <120 mg/dl
Fumitaka Tanaka et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
High-density lipoprotein subclasses and their relationship to cardiovascular disease
H. Robert Superko et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
New molecular insights into CETP structure and function: a review
M. Arthur Charles et al.
JOURNAL OF LIPID RESEARCH (2012)
Metabolic and functional relevance of HDL subspecies
Bela F. Asztalos et al.
CURRENT OPINION IN LIPIDOLOGY (2011)
Small LDL-Cholesterol is Superior to LDL-Cholesterol for Determining Severe Coronary Atherosclerosis
Shinji Koba et al.
Journal of Atherosclerosis and Thrombosis (2011)
Associations between Small Dense LDL, HDL Subfractions (HDL2, HDL3) and Risk of Atherosclerosis in Japanese-Americans
Shusaku Maeda et al.
Journal of Atherosclerosis and Thrombosis (2011)
Lipoprotein subfractions and cardiovascular disease risk
Ronald M. Krauss
CURRENT OPINION IN LIPIDOLOGY (2010)
Prevalence of Diabetes among Men and Women in China
Wenying Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus.
Lukasz Januszkiewicz
KARDIOLOGIA POLSKA (2010)
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Henry N. Ginsberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Relation Among Lipoprotein Subfractions and Carotid Atherosclerosis in Alaskan Eskimos (from the GOCADAN Study)
Maria Masulli et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
High-Density Lipoprotein Particle Size and Concentration and Coronary Risk
Karim El Harchaoui et al.
ANNALS OF INTERNAL MEDICINE (2009)
Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Russell Scott et al.
DIABETES CARE (2009)
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: Significance for cardiovascular risk - The IDEAL and EPIC-Norfolk studies
Wim A. van der Steeg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study-Implications for LDL management
William C. Cromwell et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2007)
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
A. C. Keech et al.
LANCET (2007)
Preβ 1-HDL concentration is a predictor of carotid atherosclerosis in type 2 diabetic patients
Satoshi Hirayama et al.
DIABETES CARE (2007)
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the veterans affairs high-density lipoprotein intervention trial
JD Otvos et al.
CIRCULATION (2006)
The role of high-density lipoprotein in inflammation
M Navab et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2005)
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: Results from the Diabetes Atherosclerosis Intervention Study (DAIS)
JC Ansquer et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes
K Berneis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Alterations of HDL subclasses in hyperlipidemia
YH Xu et al.
CLINICA CHIMICA ACTA (2003)
A low high density lipoprotein (HDL) level is associated with carotid artery intima-media thickness in asymptomatic members of low HDL families
C Alagona et al.
ATHEROSCLEROSIS (2002)
Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trial
RS Rosenson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Share Paper
